Seer (NASDAQ:SEER) Shares Down 2.7%

Seer, Inc. (NASDAQ:SEER)’s stock price fell 2.7% during trading on Monday . The stock traded as low as $1.77 and last traded at $1.79. 1,043,092 shares traded hands during trading, an increase of 131% from the average session volume of 451,460 shares. The stock had previously closed at $1.84.

Wall Street Analyst Weigh In

Separately, Morgan Stanley reiterated an “equal weight” rating and set a $7.00 price objective on shares of Seer in a research note on Tuesday, March 5th.

Seer Stock Down 3.4 %

The company has a market capitalization of $109.47 million, a price-to-earnings ratio of -1.25 and a beta of 1.65. The business’s 50-day moving average is $1.81 and its 200-day moving average is $1.79.

Seer (NASDAQ:SEER) last posted its earnings results on Thursday, February 29th. The company reported ($0.28) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.07. The company had revenue of $4.44 million during the quarter, compared to the consensus estimate of $4.24 million. Seer had a negative net margin of 517.84% and a negative return on equity of 20.87%. As a group, analysts expect that Seer, Inc. will post -1.22 EPS for the current year.

Insider Activity at Seer

In other Seer news, CEO Omid Farokhzad sold 52,857 shares of the company’s stock in a transaction dated Thursday, March 7th. The shares were sold at an average price of $2.03, for a total value of $107,299.71. Following the completion of the transaction, the chief executive officer now owns 1,436,285 shares in the company, valued at $2,915,658.55. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders sold 69,149 shares of company stock worth $133,366 over the last three months. Company insiders own 15.02% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of SEER. Virtu Financial LLC acquired a new position in shares of Seer in the fourth quarter worth about $28,000. GSA Capital Partners LLP purchased a new stake in shares of Seer during the fourth quarter worth about $32,000. Tower Research Capital LLC TRC increased its stake in shares of Seer by 185.1% during the second quarter. Tower Research Capital LLC TRC now owns 8,737 shares of the company’s stock worth $37,000 after purchasing an additional 5,672 shares in the last quarter. Y Intercept Hong Kong Ltd purchased a new stake in shares of Seer during the second quarter worth about $48,000. Finally, UBS Group AG increased its stake in shares of Seer by 286.7% during the third quarter. UBS Group AG now owns 6,389 shares of the company’s stock worth $49,000 after purchasing an additional 4,737 shares in the last quarter. Institutional investors and hedge funds own 75.20% of the company’s stock.

About Seer

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.